Data Collection for Low Birth Weight Infants
(GDB Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial gathers data on very low birth weight infants born at specific research centers. The goal is to collect information on their health and treatment to identify patterns and improve future care. No specific treatment is being tested; the focus is solely on observational data collection. Infants born at these centers weighing between 401 and 1,000 grams or born before 29 weeks of gestation would be a good fit for this trial. As an unphased trial, the study aims to enhance understanding and improve care for future infants, offering participants a chance to contribute to meaningful research.
Do I need to stop my current medications for this trial?
The trial information does not specify whether you need to stop taking your current medications. It seems to focus on collecting data rather than changing treatments.
Why are researchers excited about this trial?
Researchers are excited about this trial because it focuses on gathering valuable data on very low birth weight infants, which can enhance our understanding of their health outcomes. Unlike current treatments that aim to address specific health issues in these infants, this registry cohort collects comprehensive data that could inform future treatment strategies and improve long-term care. By analyzing this extensive database, researchers hope to identify patterns and factors that contribute to better health outcomes, ultimately leading to more effective and personalized interventions for these vulnerable infants.
Who Is on the Research Team?
Robin Ohls, MD
Principal Investigator
University of Utah
Anna Maria Hibbs, MD, MSCE, FAAP
Principal Investigator
Case Western Reserve University, Rainbow Babies and Children's Hospital
Waldemar A Carlo, MD
Principal Investigator
University of Alabama at Birmingham
C. Michael Cotten, MD
Principal Investigator
Duke University
Kristi L Watterberg, MD
Principal Investigator
University of New Mexico
Sara DeMauro, MD, MSCE
Principal Investigator
University of Pennsylvania
Abbot R Laptook, MD
Principal Investigator
Brown University, Women & Infants Hospital of Rhode Island
Ravi M Patel, MD, MSc
Principal Investigator
Emory University
Pablo Sanchez, MD
Principal Investigator
Research Institute at Nationwide Children's Hospital
Abhik Das, PhD
Principal Investigator
RTI International
Krisa P Van Meurs, MD
Principal Investigator
Stanford University
Carl D'Angio, MD
Principal Investigator
University of Rochester
Stephanie Merhar, MD MS
Principal Investigator
Children's Hospital Medical Center, Cincinnati
Myra Wyckoff, MD
Principal Investigator
University of Texas, Southwestern Medical Center at Dallas
Tarah Colaizy, MD, MPH
Principal Investigator
University of Iowa
Jon E Tyson, MD MPH
Principal Investigator
The University of Texas Health Science Center, Houston
Are You a Good Fit for This Trial?
Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Data Collection
Baseline data is collected soon after admission to the NICU; outcome data is collected at the time of death or discharge from the hospital
Follow-up
Participants are monitored for safety and effectiveness after treatment
Longitudinal Data Analysis
Data are analyzed to find associations and trends between baseline information, treatments, and infant outcomes
What Are the Treatments Tested in This Trial?
Interventions
- None
Find a Clinic Near You
Who Is Running the Clinical Trial?
NICHD Neonatal Research Network
Lead Sponsor
National Center for Research Resources (NCRR)
Collaborator
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Collaborator